News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .